Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to gather information on the safety and effectiveness
of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis.
People with thumb joint pain or arthritis usually receive steroid injections to help with the
pain. However, this medicine does not always work well and also carries known important side
effects. There is currently no alternative to this injection medicine.
This clinical trial seeks to investigate botulinum toxin as a possible alternative to steroid
injection. The difference between Botox and steroid injections is that they are different
medicines and work in different ways. Botox, as it is being used in this study, is not
FDA-approved. It is therefore considered an investigational medicine.